Halozyme Therapeutics

Price & Volume

Stats

Open	$57.32
Previous Close	$57.77
Day Range	$56.68-$57.41
52W Range	$37.73-$65.53
Market Cap	$7.1B
Shares Short	9M

Financials

Revenue (12 Mos)	$1B
Revenue Growth (YoY)	29.5%
Gross Profit (12 Mos)	$855.9M
Diluted EPS	$3.43

News

Yahoo Finance • 8 days ago

Halozyme Therapeutics, Inc. (HALO): A Cheap Biotech Stock to Invest In Now

Yahoo Finance • 10 months ago

Halozyme to Report First Quarter 2024 Financial and Operating Results

Yahoo Finance • last year

Halozyme Announces argenx Received Approval in Japan for VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Co-Formulated with ENHANZE® for Generalized Myasthenia Gravis

Yahoo Finance • last year

Halozyme Announces Takeda Receives FDA Approval for HYQVIA® Co-formulated with ENHANZE® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

About

CEO	Dr. Helen I. Torley M.B. Ch. B., M.R.C.P.
Address	12390 El Camino Real, San Diego, CA, United States, 92130
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	0